Hepatocellular carcinoma: Beyond the boundaries of age

Anti-Cancer Agents in Medicinal Chemistry

Volumn 13, Issue 9, 2013, Pages 1371-1377

  Di Benedetto, Fabrizio ^a   Tarantino, Giuseppe ^a   Quintini, Cristiano ^b   Tirelli, Umberto ^c   Berretta, Massimiliano ^c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Digestive Disease Institute   (United States)

^c CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Ablative treatment; Elderly; Hepatocellular carcinoma; Liver resection; Liver transplantation; Review; Sorafenib

Indexed keywords

ALPHA FETOPROTEIN; B RAF KINASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN TYROSINE KINASE; SORAFENIB; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3; ANTINEOPLASTIC AGENT;

ALCOHOL ABUSE; APOPTOSIS; CARDIOVASCULAR DISEASE; CHEMOEMBOLIZATION; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; HUMAN; HYPERINSULINEMIA; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FUNCTION; LIVER RESECTION; LIVER TRANSPLANTATION; MULTIMODALITY CANCER THERAPY; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 3 CLINICAL TRIAL (TOPIC); RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; AGED; CARCINOMA, HEPATOCELLULAR; LIVER NEOPLASMS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION;

EID: 84888249701     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/18715206113136660342     Document Type: Review

References (85)

1. Quaglia, A., Capocaccia, R., Micheli, A., Carrani, E., Vercelli, M. A wide difference in cancer survival between middle aged and elderly patients in Europe. Int. J. Cancer, 2007, 120, 2196-2201.
2. Bosch, F.X., Ribes, J., Diaz, M., Díaz, M., Cléries, R. Primary liver cancer: Worldwide incidence and trends. Gastroenterology, 2004, 127 (5 suppl. 1), s5-s16.
3. El-Serag, H.B., Mason, A.C., Key, C. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology, 2001, 33(1), 62-65.
4. Mirici-Cappa, F., Gramenzi, A., Santi, V., Zambruni, A., Di Micoli, A., Frigerio, M., Maraldi, F., Di Nolfo, M.A., Del Poggio, P., Benvegnù, L., Rapaccini, G., Farinati, F., Zoli, M., Borzio, F., Giannini, E.G., Caturelli, E., Bernardi, M., Trevisani, F., Italian Liver Cancer Group. Treatments for hepatocellular carcinoma in elderly mpatients are as effective as in younger patients: A 20-year multicentre experience. Gut, 2010, 59, 387-396.
5. Kozyreva, O.N., Chi, D., Clark, J.W., Wang, H., Theall, K.P., Ryan, D.P., Zhu, A.X. A Multicenter Retrospective Study on Clinical Characteristics,Treatment Patterns, and Outcome in Elderly Patients with Hepatocellular Carcinoma. Oncologist, 2011, 16, 310-318.
6. Liaw, Y.F., Tai, D.I., Chu, C.M., Lin, D.Y., Sheen, I.S., Chen, T.J., Pao, C.C. Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study. Gastroenterology, 1986, 90, 263-267.
7. Armstrong, G.L., Wasley, A., Simard, E.P., McQuillan, G.M., Kuhnert, W.L., Alter, M.J. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann. Intern. Med., 2006, 144, 705-714.
8. Lui, W.Y., Chau, G.Y., Wu, C.W., King, K.L. Surgical resection of hepatocellular carcinoma in elderly cirrhotic patients. Hepatogastroenterology, 1999, 46(26), 640-645.
9. Takenaka, K., Shimada, M., Higashi, H., Adachi, E., Nishizaki, T., Yanaga, K., Matsumata, T., Ikeda, T., Sugimachi, K. Liver resection for hepatocellular carcinoma in the elderly. Arch. Surg., 1994, 129(8), 846-850.
10. Yanaga, K., Kanematsu, T., Takenaka, K., Matsumata, T., Yoshida, Y., Sugimachi, K. Hepatic resection for hepatocellular carcinoma in elderly patients. Am J Surg, 1988, 155(2), 238-241.
11. Oishi, K., Itamoto, T., Kobayashi, T., Oshita, A., Amano, H., Ohdan, H., Tashiro, H., Asahara, T. Hepatectomy for hepatocellular carcinoma in elderly patients aged 75 years or more. J. Gastrointest. Surg., 2009, 13(4), 695-701.
12. Ferrero, A., Viganò, L., Polastri, R., Ribero, D., Lo Tesoriere, R., Muratore, A., Capussotti, L. Hepatectomy as treatment of choice for hepatocellular carcinoma in elderly cirrhotic patients. World J. Surg., 2005, 29(9), 1101-1105.
13. Kaibori, M., Matsui, K., Ishizaki, M., Saito, T., Kitade, H., Matsui, Y., Kwon, A.H. Hepatic resection for hepatocellular carcinoma in the elderly. J. Surg. Oncol., 2009, 99(3), 154-160.
14. Massarweh, N.N., Park, J.O., Yeung, R.S., Flum, D.R. Comparative assessment of the safety and effectiveness of radiofrequency ablation among elderly medicare beneficiaries with hepatocellular carcinoma. Ann. Surg. Oncol., 2012, 19, 1058-1065.
15. Schwartz, J.J., Pappas, L., Thiesset, H.F., Vargas, G., Sorensen, J.B., Kim, R.D., Hutson, W.R., Boucher, K., Box, T. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: The National experience. Liver Transplantation, 2012, 18, 423-433.
16. Perkins, J.D. Treatment of an elderly patient with hepatocellular carcinoma: Counseling from the patient's point of view. Liver Transplantation, 2012, 18, 391-394.
17. Frith, J., Newton, J. Liver transplantation in more elderly age. Transpl. Int., 2009, 22(6), 599-600.
18. Balducci, L. Geriatric oncology: challenges for the new century. Eur. J. Cancer, 2000, 36, 1741-1754.
19. Extermann, M., Aapro, M. Assessment of the older cancer patient. Hematol. Oncol. Clin. N. Am., 2000, 14, 63-78.
20. Extermann, M. Measuring comorbidity in the older cancer patient. Eur. J. Cancer, 2000, 36, 453-471.
21. Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T., Carbone, P.P. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am. J. Clin. Oncol., 1982, 5, 649-655.
22. Di Benedetto, F., Berretta, M., D'Amico, G., Montalti, R., De Ruvo, N., Cautero, N., Guerrini, G.P., Ballarin, R., Spaggiari, M., Tarantino, G., Di Sandro, S., Pecchi, A., Luppi, G., Gerunda, G.E. Liver resection for colorectal metastases in older adults: A paired matched analysis. J. Am. Geriatr. Soc., 2011, 59(12), 2282-2290.
23. Charlson, M., Szatrowski, T.P., Peterson, J., Gold, J. Validation of a combined comorbidity index. J. Clin. Epidemiol., 1994, 47, 1245-1251.
24. Conwell, Y., Forbes, N.T., Cox, C., Caine, E.D. Validation of a measure of physical illness burden at autopsy. The cumulative illness rating scale. J. Am. Ger. Soc., 1993, 41, 38-41.
25. Jing-Lin, X., Sharma, D., Bing-Hui, Y., Bo-Heng, Z., Zeng-Chen, M., Zhi-Quan, W., Jia, F., Xin, Z.D., Lun-Xiu, Q., Zhao-You, X. Analysis of the clinicopathological features of hepatocellular carcinoma in elderly patients. J. Nepal. Med. Assoc., 2008, 47, 132-135.
26. Huang, J., Li, B.K., Chen, G.H., Li, J.Q., Zhang, Y.Q., Li, G.H., Yuan, Y.F. Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy. J. Gastrointest. Surg., 2009, 13, 1627-1635.
27. Tsukioka, G., Kakizaki, S., Sohara, N., Sato, K., Takagi, H., Arai, H., Abe, T., Toyoda, M., Katakai, K., Kojima, A., Yamazaki, Y., Otsuka, T., Matsuzaki, Y., Makita, F., Kanda, D., Horiuchi, K., Hamada, T., Kaneko, M., Suzuki, H., Mori, M. Hepatocellular carcinoma in extremely elderly patients: An analysis of clinical characteristics, prognosis and patient survival. World J. Gastroenterol., 2006, 12, 48-53.
28. Arase, Y., Kobayashi, M., Suzuki, F., Suzuki, Y., Kawamura, Y., Akuta, N., Imai, N., Kobayashi, M., Sezaki, H., Matsumoto, N., Saito, S., Hosaka, T., Ikeda, K., Kumada, H., Ohmoto, Y., Amakawa, K., Hsieh, S.D., Ogawa, K., Tanabe, M., Tsuji, H., Kobayashi, T. Difference in malignancies of chronic liver disease due to non-alcoholic fatty liver disease or hepatitis C in Japanese elderly patients. Hepatol. Res., 2012, 42(3), 264-272.
29. Vega, G.L., Chandalia, M., Szczepaniak, L.S., Grundy, S.M. Metabolic correlates of nonalcoholic fatty liver in women and men. Hepatology, 2007, 46, 716-722.
30. Van der Poorten, D., Milner, K.L., Hui, J., Hodge, A., Trenell, M.I., Kench, J.G., London, R., Peduto, T., Chisholm, D.J., George, J. Visceral fat a key mediator of steatohepatitis in metabolic liver disease. Hepatology, 2008, 48, 449-457.
31. Alexia, C., Fallot, G., Lasfer, M., Schweizer-Groyer, G., Groyer, A. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signaling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis. Biochem. Pharmacol., 2004, 68, 1003-1015.
32. Nakajima, T., Nakashima, T., Yamaoka, J., Shibuya, A., Konishi, E., Okada, Y., Jo, M., Nishikawa, T., Itoh, Y., Yoshikawa, T. Greater age and hepatocellular aging are independent risk factors for hepatocellular carcinoma arising from non-B non-C nonalcoholic chronic liver disease. Pathol. Int., 2011, 61(10), 572-576.
33. Kawamura, Y., Arase, Y., Ikeda, K., Seko, Y., Imai, N., Hosaka, T., Kobayashi, M., Saitoh, S., Sezaki, H., Akuta, N., Suzuki, F., Suzuki, Y., Ohmoto, Y., Amakawa, K., Tsuji, H., Kumada, H. Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma. Am. J. Gastroenterol., 2012,107(2), 253-261.
34. de Lope, C.R., Tremosini, S., Forner, A., Reig, M., Bruix, J. Management of HCC. J. Hepatol., 2012, 56 Suppl 1, S75-S87.
35. Croswell, J.M., Ransohoff, D.F., Kramer, B.S. Principles of cancer screening: Lessons from history and study design issues. Semin. Oncol., 2010, 37, 202-215.
36. Bruix, J., Sherman, M. Management of hepatocellular carcinoma: An update. Hepatology, 2011, 53, 1020-1022.
37. Singal, A., Volk, M.L., Waljee, A., Salgia, R., Higgins, P., Rogers, M.A., Marrero, J.A. Meta-analysis: Surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment. Pharmacol. Ther., 2009, 30, 37-47.
38. Lok, A.S., Sterling, R.K., Everhart, J.E., Wright, E.C., Hoefs, J.C., Di Bisceglie, A.M., Morgan, T.R., Kim, H.Y., Lee, W.M., Bonkovsky, H.L., Dienstag, J.L., HALT-C Trial Group. Desgamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Gastroenterology, 2010, 138, 493-502.
39. Kojiro, M., Roskams, T. Early hepatocellular carcinoma and dysplastic nodules. Semin. Liver. Dis., 2005, 25, 133-142.
40. Yamamoto, K., Takenaka, K., Matsumata, T., Shimada, M., Itasaka, H., Shirabe, K., Sugimachi, K. Right hepatic lobectomy in elderly patients with hepatocellular carcinoma. Hepatogastroenterology, 1997, 44, 514-518.
41. Haga, Y., Wada, Y., Takeuchi, H., Kimura, O., Furuya, T., Sameshima, H., Ishikawa, M. Estimation of physiologic ability and surgical stress (E-PASS) for a surgical audit in elective digestive surgery. Surgery, 2004, 135, 586-594.
42. Yanaga, K., Kanematsu, T., Takenaka, K., Matsumata, T., Yoshida, Y., Sugimachi, K. Hepatic resection for hepatocellular carcinoma in elderly patients. Am. J. Surg., 1988, 155, 238-241.
43. Fortner, J.G., Lincer, R.M. Hepatic resection in the elderly. Ann. Surg., 1990, 211, 141-145.
44. Hanazaki, K., Kajikawa, S., Shimozawa, N., Shimada, K., Hiraguri, M., Koide, N., Adachi, W., Amano, J. Hepatic resection for hepatocellular carcinoma in the elderly. J. Am. Coll. Surg., 2001, 192, 38-46.
45. Nagasue, N., Chang, Y.C., Takemoto, Y., Taniura, H., Kohno, H., Nakamura, T. Liver resection in the aged (seventy years or older) with hepatocellular carcinoma. Surgery, 1993, 113, 148-154.
46. Takenaka, K., Shimada, M., Higashi, H., Adachi, E., Nishizaki, T., Yanaga, K., Matsumata, T., Ikeda, T., Sugimachi, K. Liver resection for hepatocelluar carcinoma in the elderly. Arch. Surg., 1994, 129, 846-850.
47. Fong, Y., Brennan, M.F., Cohen, M., Heffernan, N., Freiman, A., Blumgart, L.H. Liver resection in the elderly. Br. J. Surg., 1997, 84, 1386-1390.
48. Galanakis, P., Bickel, H., Gradinger, R., Von Gumppenberg, S., Förstl, H. Acute confusional state in the elderly: Incidence, risk factors and complication. Int. J. Geriatr. Psychiatry, 2001, 16, 349-355.
49. Okeeffe, S.T., Chonchubhari, A.N. Postoperative delirium in the elderly. Br. J. Anaesth., 1994, 73, 673-687.
50. Cho, S.W., Steel, J., Tsung, A., Marsh, J.W., Geller, D.A., Gamblin, T.C. Safety of liver resection in the elderly: How important is age? Ann. Surg. Oncol., 2011, 18(4), 1088-1095.
51. Nanashima, A., Abo, T., Nonaka, T., Fukuoka, H., Hidaka, S., Takeshita, H., Ichikawa, T., Sawai, T., Yasutake, T., Nakao, K., Nagayasu, T. Prognosis of patients with hepatocellular carcinoma after hepatic resection: are elderly patients suitable for surgery? J. Surg. Oncol., 2011, 104(3), 284-291.
52. Haga, Y., Ikei, S., Ogawa, M. Estimation of Physiologic Ability and Surgical Stress (E-PASS) as a new prediction scoring system for postoperative morbidity and mortality following elective gastrointestinal surgery. Surg. Today, 1999, 29, 219-225.
53. Nakamuta, M., Morizono, S., Kohjima, M., Kotoh, K., Enjoji, M. Baseline characterization of patients aged 70 years and above with hepatocellular carcinoma. World J. Gastroenterol. 2005, 11, 7512-7514.
54. Kondo, K., Chijiiwa, K., Funagayama, M., Kai, M., Otani, K., Ohuchida, J. Hepatic resection is justified for elderly patients with hepatocellular carcinoma. World J. Surg., 2008, 32(10), 2223-2229.
55. Dindo, D., Demartines, N., Clavien, P.A. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg., 2004, 240(2), 205-213.
56. Karnofsky, D.A., Burchenal J.H. In Evaluation of Chemotherapeutic Agents, MacLeod CM, Ed., Columbia University Press. 1949, Page 196.
57. Takahashi, H., Mizuta, T., Kawazoe, S., Eguchi, Y., Kawaguchi, Y., Otuka, T., Oeda, S., Ario, K., Iwane, S., Akiyama, T., Ozaki, I., Fujimoto, K. Efficacy and safety of radiofrequency ablation for elderly hepatocellular carcinoma patients. Hepatol. Res., 2010, 40, 997-1005.
58. Tateishi, R., Shiina, S., Teratani, T., Obi, S., Sato, S., Koike, Y., Fujishima, T., Yoshida, H., Kawabe, T., Omata, M. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer, 2005, 103, 1201-1209.
59. Kao, W.Y., Chiou, Y.Y., Hung, H.H., Su, C.W., Chou, Y.H., Huo, T.I., Huang, Y.H., Wu, W.C., Lin, H.C., Lee, S.D., Wu, J.C. Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy. J. Clin. Gastroenterol., 2012, 46, 62-70.
60. Shiina, S., Tateishi, R., Arano, T., Uchino, K., Enooku, K., Nakagawa, H., Asaoka, Y., Sato, T., Masuzaki, R., Kondo, Y., Goto, T., Yoshida, H., Omata, M., Koike, K. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am. J. Gastroenterol., 2012, 107(4), 569-577
61. De Giorgio, M., Vezzoli, S., Cohen, E., Armellini, E., Luc a, M.G., Verga, G., Pinelli, D., Nani, R., Valsecchi, M.G., Antolini, L., Colledan, M., Fagiuoli, S., Strazzabosco, M. Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria. Liver Transpl., 2010, 16, 503-512.
62. Thornton, R.H., Covey, A., Petre, E.N., Riedel, E.R., Maluccio, M.A., Sofocleous, C.T., Brody, L.A., Getrajdman, G.I., D'Angelica, M., Fong, Y., Brown, K.T. A comparison of outcomes from treating hepatocellular carcinoma by hepatic artery embolization in patients younger or older than 70 years. Cancer, 2009, 115(21), 5000-5006.
63. Collier, J.D., Curless, R., Bassendine, M.F., James, O.F. Clinical features and prognosis of hepatocellular carcinoma in Britain in relation to age. Age Ageing, 1994, 23(1), 22-27.
64. Di Benedetto F., Tarantino G., Montalti R, et al. Laparoscopic radiofrequency ablation in the caudate lobe for hepatocellular carcinoma before liver transplantation. J. Laparoendosc Adv. Surg. Tech. A., 2012, 22(4), 400-2.
65. Giannini, E., Romagnoli, P., Fasoli, A., Botta, F., Risso, D., Testa, R. Influence of age on clinical presentation, therapeutic options, and prognosis in anti-HCV positive cirrhotic patients with hepatocellular carcinoma. Age Ageing, 2002, 31(6), 457-62.
66. Dohmen, K., Shirahama, M., Shigematsu, H., Irie, K., Ishibashi, H. Optimal treatment strategy for elderly patients with hepatocellular carcinoma. J. Gastroenterol. Hepatol., 2004, 19(8), 859-865.
67. Poon RT, Fan ST, Lo CM, et al. Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol., 1999, 94(9):2460-6.
68. Wong, H., Tang, Y.F., Yao, T.J., Chiu, J., Leung, R., Chan, P., Cheung, T.T., Chan, A.C., Pang, R.W., Poon, R., Fan, S.T., Yau, T. The outcomes and safety of single-agent sorafenib in the treatment of elderly patients with advanced hepatocellular carcinoma (HCC). Oncologist, 2011, 16(12), 1721-1728.
69. Keating, G.M., Santoro, A. Sorafenib: a review of its use in advanced hepatocellular carcinoma. Drugs, 2009, 69(2), 223-240.
70. Smalley, K.S., Xiao, M., Villanueva, J., Nguyen, T.K., Flaherty, K.T., Letrero, R., Van Belle, P., Elder, D.E., Wang, Y., Nathanson, K.L., Herlyn, M. CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations. Oncogene, 2009, 28(1), 85-94.
71. Wilhelm, S.M., Adnane, L., Newell, P., Villanueva, A., Llovet, J.M., Lynch, M. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Mol. Cancer Ther., 2008, 7(10), 3129-3140.
72. Wilhelm, S.M., Carter, C., Tang, L., Wilkie, D., McNabola, A., Rong, H., Chen, C., Zhang, X., Vincent, P., McHugh, M., Cao, Y., Shujath, J., Gawlak, S., Eveleigh, D., Rowley, B., Liu, L., Adnane, L., Lynch, M., Auclair, D., Taylor, I., Gedrich, R., Voznesensky, A., Riedl, B., Post, L.E., Bollag, G., Trail, P.A. BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Res., 2004, 64(19), 7099-7109.
73. Ito, Y., Sasaki, Y., Horimoto, M., Wada, S., Tanaka, Y., Kasahara, A., Ueki, T., Hirano, T., Yamamoto, H., Fujimoto, J., Okamoto, E., Hayashi, N., Hori, M. Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma. Hepatology, 1998, 27(4), 951-958.
74. Villanueva, A., Newell, P., Chiang, D.Y., Friedman, S.L., Llovet, J.M. Genomics and signaling pathways in hepatocellular carcinoma. Semin. Liver Dis., 2007, 27(1), 55-76.
75. Calvisi, D.F., Ladu, S., Gorden, A., Farina, M., Conner, E.A., Lee, J.S., Factor, V.M., Thorgeirsson, S.S. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. Gastroenterology, 2006, 130(4), 1117-1128.
76. Llovet, J.M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.F., de Oliveira, A.C., Santoro, A., Raoul, J.L., Forner, A., Schwartz, M., Porta, C., Zeuzem, S., Bolondi, L., Greten, T.F., Galle, P.R., Seitz, J.F., Borbath, I., Häussinger, D., Giannaris, T., Shan, M., Moscovici, M., Voliotis, D., Bruix, J., SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma. N. Engl. J. Med., 2008, 359(4), 378-390.
77. Berretta, M., Di Benedetto, F., Dal Maso, L., Cacopardo, B., Nasti, G., Facchini, G., Bearz, A., Spina, M., Garlassi, E., De Re, V., Fiorica, F., Lleshi, A., Tirelli, U. Sorafenib for the treatment of unresectable hepatocellular carcinoma in HIV-positive patients. Anticancer Drugs, 2013, 24(2), 212-218.
78. Nunnari, G., Berretta, M., Pinzone, M.R., Di Rosa, M., Berretta, S., Cunsolo, G., Malaguarnera, M., Cosentino, S., De Paoli, P., Schnell, J.M., Cacopardo, B. Hepatocellular carcinoma in HIV positive patients. Eur. Rev. Med Pharmacol. Sci., 2012, 16(9), 1257-1270.
79. Berretta, M., Garlassi, E., Cacopardo, B., Cappellani, A., Guaraldi, G., Cocchi, S., De Paoli, P., Lleshi, A., Izzi, I., Torresin, A., Di Gangi, P., Pietrangelo, A., Ferrari, M., Bearz, A., Berretta, S., Nasti, G., Di Benedetto, F., Balestreri, L., Tirelli, U., Ventura, P. Hepatocellular carcinoma in HIV-infected patients: check early, treat hard. Oncologist, 2011, 16(9), 1258-1269.
80. Di Benedetto, F., Berretta, M., De Ruvo, N., Tarantino, G., D'Amico, G., Ballarin, R., Iemmolo, R.M., Gerunda, G.E. Is advanced hepatocellular carcinoma amenable of cure by liver transplantation with sorafenib as a neoadjuvant approach plus m-TOR inhibitors monotherapy. J. Surg. Oncol., 2012, 105(1), 111-112.
81. Tavio, M., Grossi, P., Baccarani, U., Scudeller, L., Pea, F., Berretta, M., Adani, G., Vivarelli, M., Riva, A., Tirelli, U., Bresadola, V., Viale, P., Risaliti, A. HIV-infected patients and liver transplantation: Who, when and why. Curr. HIV. Res., 2011, 9(2), 120-127.
82. Berretta, M., Zanet, E., Di Benedetto, F., Simonelli, C., Bearz, A., Morra, A., Bonanno, S., Berretta, S., Tirelli, U. Unusual presentation of metastatic hepatocellular carcinoma in an HIV/HCV coinfected patient: Case report and review of the literature. Tumori, 2008, 94(4), 589-591.
83. Di Benedetto, F., Di Sandro, S., De Ruvo, N., Berretta, M., Montalti, R., Guerrini, GP., Ballarin, R., De Blasiis, M.G., Spaggiari, M., Smerieri, N., Iemmolo, R.M., Guaraldi, G., Gerunda, G.E. Human immunodeficiency virus and liver transplantation: Our point of view. Transplant, Proc., 2008, 40(6), 1965-1971.
84. Di Benedetto, F., De Ruvo, N., Berretta, M., Masetti, M., Montalti, R., Di Sandro, S., Ballarin, R., Codeluppi, M., Guaraldi, G., Gerunda, G.E. Hepatocellular carcinoma in HIV patients treated by liver transplantation. Eur. J. Surg. Oncol., 2008, 34(4), 422-427.
85. Di Benedetto, F., De Ruvo, N., Berretta, M., Masetti, M., Montalti, R., Di Sandro, S., Quintini, C., Codeluppi, M., Tirelli, U., Gerunda, G.E. Don't deny liver transplantation to HIV patients with hepatocellular carcinoma in the highly active antiretroviral therapy era. J. Clin. Oncol., 2006, 24(14), e26-e27.